HealthCare Global Enterprises (HCG) announced the approval of its unaudited financial results for Q3 2026. Key decisions from the board meeting include the introduction of the HCG Employee Stock Option Scheme 2026 (ESOP 2026), aimed at incentivizing eligible employees. Dr. Naveen R. Nagar has been appointed as Head – Clinical Strategy, and Mr. Pankaj Gautam as Chief Information Officer. The board meeting concluded at 7:35 p.m.
Financial Performance Highlights
HealthCare Global Enterprises (HCG) released its unaudited financial results, showcasing the company’s performance. The results, approved on February 5, 2026, reflect the company’s operational and financial standing for the quarter and nine months ending December 31, 2025.
Introduction of ESOP 2026
The Board approved the introduction and adoption of the HCG Employee Stock Option Scheme 2026 (ESOP 2026). This scheme allows the company to grant stock options to eligible employees and subsidiaries, subject to shareholder and regulatory approvals. The maximum number of shares that can be issued under the HCG ESOS 2026 shall be 74,21,455.
Leadership Appointments
HCG has appointed key personnel to leadership roles. Dr. Naveen R. Nagar is now the Head of Clinical Strategy, and Mr. Pankaj Gautam has been named Chief Information Officer, both designated as Senior Management Personnel of the Company. Detailed disclosures regarding these appointments will be made separately.
Consolidated Financial Results Overview
The consolidated financial results show a total income of ₹63,554 lakhs for the quarter ended December 31, 2025, compared to ₹56,321 lakhs in the corresponding quarter of the previous year. The total comprehensive income for the period is ₹2,164 lakhs.
Standalone Financial Results Overview
The standalone financial results show a total income of ₹34,515 lakhs for the quarter ended December 31, 2025, compared to ₹31,780 lakhs in the corresponding quarter of the previous year. The total comprehensive income/(loss) for the period is (₹88) lakhs.
Source: BSE
